Date Title Format

05/12/2007

Holding(s) in Company

PDF

05/12/2007

Holding(s) in Company

PDF

04/12/2007

Holding(s) in Company

PDF

30/11/2007

Total Voting Rights

PDF

22/11/2007

Holding(s) in Company

PDF

21/11/2007

Director/PDMR Shareholding

HTML Page

20/11/2007

Result of EGM

PDF

20/11/2007

Statement of EGM

PDF

14/11/2007

Holding(s) in Company

PDF

09/11/2007

Holding(s) in Company

PDF

08/11/2007

Holding(s) in Company

PDF

31/10/2007

Zolpidem on BBC 1 Documentary

HTML Page

29/10/2007

Notification of Major Interest in Shares

PDF

11/10/2007

Holding(s) in Company

PDF

01/10/2007

Product Launch

HTML Page

27/09/2007

Research Update

HTML Page

20/09/2007

Interim Results

PDF

19/09/2007

Change of Advisors

HTML Page

23/08/2007

Research Update

HTML Page

21/08/2007

Notification of Major Interest in Shares

PDF

10/08/2007

Notification of Major Interest in Shares

PDF

01/08/2007

Website Compliance

HTML Page

29/06/2007

Total Voting Rights

HTML Page

21/06/2007

Holding(s) in Company

PDF

20/06/2007

Holding(s) in Company

PDF

14/06/2007

Issue of Equity

HTML Page

11/06/2007

Research Update

HTML Page

07/06/2007

ReGen’s Cognitive Nutraceutical Colostrinin™ Launched in Australasia

HTML Page

15/05/2007

Results of Annual General Meeting

HTML Page

05/05/2007

AGM Statement

HTML Page

24/04/2007

Notice of AGM

HTML Page

19/04/2007

Holding(s) in Company

PDF

19/03/2007

Preliminary results to 31 December 2006

PDF

28/02/2007

Total Voting Rights

HTML Page

14/02/2007

Holding(s) in Company

PDF

14/02/2007

Holding(s) in Company

PDF

14/02/2007

Holding(s) in Company

PDF

12/02/2007

Holding(s) in Company

PDF

12/02/2007

Holding(s) in Company

PDF

12/02/2007

Holding(s) in Company

PDF

06/02/2007

Issue of Equity

HTML Page

05/02/2007

Research Update

HTML Page

02/02/2007

Holding(s) in Company

HTML Page

15/01/2007

Holding(s) in Company

HTML Page

20/12/2006

Total Voting Rights and Share Capital

HTML Page

15/12/2006

Holding(s) in Company

HTML Page

12/12/2006

Director/PDMR Shareholding

HTML Page

11/12/2006

5th Annual City Presentation

HTML Page

07/12/2006

Research Update

HTML Page

05/12/2006

Director Shareholding

HTML Page

05/12/2006

Director Shareholding

HTML Page

26/09/2006

EGM Statement

HTML Page

26/09/2006

Interim Results for the Six Months to 30 June 2006

PDF

12/09/2006

Guardian Article: Zolpidem ‘Reborn’

HTML Page

01/09/2006

Notice of EGM

HTML Page

25/08/2006

Research Update

HTML Page

17/08/2006

Change of Adviser

HTML Page

21/07/2006

Issue of Equity

HTML Page

14/07/2006

Trading Statement

HTML Page

13/07/2006

Licence Agreement

HTML Page

04/07/2006

Statement in response to press comment

HTML Page

13/06/2006

AGM Statement

HTML Page

23/05/2006

BBC Article: Pill ‘reverses’ vegetative state

HTML Page

22/05/2006

Research Update

HTML Page

19/05/2006

Notice of AGM

HTML Page

12/05/2006

Issue of Equity

HTML Page

09/05/2006

Research Update

HTML Page

15/03/2006

Chairman’s Statement and preliminary results to 31 December 2005

PDF

14/02/2006

Acquisition

HTML Page

08/02/2006

ReGen to acquire Sciencom Limited

HTML Page

01/01/2006

Research Update

HTML Page

06/12/2005

December City Presentation

PDF

10/10/2005

EGM Statement

HTML Page

28/09/2005

Research Update

HTML Page

22/09/2005

Declaration of Shareholding in ReGen Therapeutics Plc

HTML Page

20/09/2005

Declaration of Shareholding in ReGen Therapeutics Plc

HTML Page

15/09/2005

Committed Share Finance Facility

HTML Page

15/09/2005

ReGen Therapeutics Plc places £1,556,000 of shares

HTML Page

15/09/2005

Interim Results for the Six Months’ to 30 June 2005

PDF

10/08/2005

ReGen Therapeutics announces grant of U.S. patent on use of Colostrinin(tm) to promote induction of Cytokines

HTML Page

18/07/2005

ReGen Therapeutics Plc Appoints New Broker

HTML Page

27/06/2005

Research Update

HTML Page

20/06/2005

ReGen Achieves Production Scale-Up Milestone for Colostrinin(TM)

HTML Page

13/06/2005

Director Shareholding

HTML Page

09/06/2005

ReGen Acquires Rights To New Use for Well Known Drug

HTML Page

24/04/2005

Results of Annual General Meeting and Directorate Change

HTML Page

15/03/2005

Statement re ADR’s

HTML Page

08/03/2005

Regen Therapeutics Plc appoints additional non-executive director

HTML Page

04/03/2005

ReGen Therapeutics announces grant of U.S. patent on use of Colostrinin in Dementia

HTML Page

14/02/2005

Regen Therapeutics announces grant of U.S. patent on use of Colostrinin(tm) to promote neuronal cell differentiation

HTML Page

14/02/2005

Disclosure of notifiable interest – Disposal of shares

HTML Page

09/02/2005

Preliminary Results 2004

PDF

07/02/2005

Disclosure of notifiable interest – Disposal of shares

HTML Page

01/02/2005

Substantial shareholding

HTML Page

21/12/2004

Director’s Interests

HTML Page

14/12/2004

ReGen Therapeutics Plc Placing raises £1.25m

HTML Page

13/12/2004

Research Update

HTML Page PDF

10/12/2004

ReGen Therapeutics Plc establishes Level-1 American Depositary Receipt Programme (+ FAQ’s as PDF)

HTML Page PDF

10/12/2004

Annual City Presentation

HTML Page

02/12/2004

Preliminary results to 31 December 2003

HTML Page
Get Adobe Reader If you are unable to view the PDF documents you may need to download the free Adobe Reader